RT Journal Article
SR Electronic
T1 BET 1: Levosimendan in septic shock
JF Emergency Medicine Journal
JO Emerg Med J
FD BMJ Publishing Group Ltd and the British Association for Accident & Emergency Medicine
SP 508
OP 510
DO 10.1136/emermed-2014-203854.1
VO 31
IS 6
YR 2014
UL http://emj.bmj.com/content/31/6/508.2.abstract
AB A shortcut review was carried out to establish whether levosimendan improves outcome in septic shock. Eight studies were directly relevant to the question. The author, date and country of publication, patient groups studied, study type, relevant outcomes, results and study weaknesses of these papers are tabulated. The clinical bottom line is that there is as yet no evidence that levosimendan reduces mortality from septic shock. The LeoPARDS trial may change that.